Skip to content

AbbVie '3D' combination cures 99% of genotype 1b hepatitis C

Prof. Rajendar Reddy, of the University of Pennsylvania Hospital, presenting at CROI 2014. Photo by Liz Highleyman, hivandhepatitis.com.

Simeprevir cures almost 80% of first-time co-infected hepatitis C patients

Prof. Douglas Dieterich of Mount Sinai School of Medicine discusses recent advances in treatment of hepatitis C and HIV co-infection at CROI 2014. Photo by Liz Highleyman / hivandhepatitis.com

Faldaprevir plus interferon and ribavirin cures hepatitis C in most people with HIV/HCV co-infection

Douglas Dieterich, presenting at CROI 2014. Photo by Liz Highleyman, hivandhepatitis.com.

Six-week oral treatment can cure hard-to-treat hepatitis C patients

Anita Kohli, presenting at CROI 2014. Photo by Liz Highleyman, hivandhepatitis.com.

Close link between HIV and hepatitis C transmission networks

US medical societies launch new hepatitis C treatment guidelines

Testing HCV positive has a sustained impact on drug injecting behaviour

Low lymphocyte count a risk factor for infections for people taking HCV therapy

Life expectancy now considerably exceeds the average in some people with HIV in the US